Baird reports 21,075-share stake in Sanara MedTech
Sanara MedTech Inc. beneficial ownership disclosure: Baird Trust Company, Baird Financial Corporation and Baird Financial Group, Inc. report aggregated beneficial ownership of 21,075 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sanara MedTech Inc. beneficial ownership disclosure: Baird Trust Company, Baird Financial Corporation and Baird Financial Group, Inc. report aggregated beneficial ownership of 21,075 shares of Common Stock. The filing bases the percentage on 9,167,040 Shares outstanding as of March 20, 2026.
The reporting persons state the shares reflect shared voting and dispositive power held by Baird Trust Company on behalf of clients. Ownership is reported as 5% or less of the class.
Insights
Small, passive position reported by Baird entities via voting discretion.
The filing lists 21,075 shares as subject to shared voting and dispositive power by Baird Trust Company, aggregated with parent entities for reporting under Rule 13d-4. The position equals a de minimis percentage of the reported class.
Impact is limited: the disclosure documents custodial/investment-discretion arrangements rather than an active control stake; subsequent filings would show any material change in holdings.
Aggregation and attribution reflect standard Rule 13d-3/13d-4 mechanics.
The Schedule 13G/A aggregates holdings of BTC, BFC, and BFG per Release No. 34-39538 and clarifies parent/subsidiary relationships. It also includes the issuer's outstanding share base used to calculate the percentage.
Watch for later amendments if voting authority or beneficial ownership changes; current disclosure states ownership remains under the 5% threshold.
Key Figures
Key Terms
Rule 13d-3 regulatory
Release No. 34-39538 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Baird report in Sanara MedTech (SMTI)?
How was the ownership percentage for SMTI calculated?
Does the filing indicate Baird controls SMTI?
Which entities are named as reporting persons in the Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.